Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
Turnstone Biologics Corp. (TSBX)
Company Research
Source: GlobeNewswire
SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced with sadness that P. Joseph Campisi, Jr., Esq, the Company’s Chief Legal Officer, passed away on February 1, 2024, following a prolonged battle with cancer. Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, commented, “This is a moment of profound sadness for those of us who had the privilege of knowing Joseph. His contributions have left an indelible mark on Turnstone and on the lives of the many colleagues he inspired throughout his distinguished career, friends and family whom he cherished, and cancer patients who will continue to benefit from his tireless efforts and advocacy. Joseph will be deeply remembered for his remark
Show less
Read more
Impact Snapshot
Event Time:
TSBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSBX alerts
High impacting Turnstone Biologics Corp. news events
Weekly update
A roundup of the hottest topics
TSBX
News
- Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsGlobeNewswire
- Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceGlobeNewswire
- Turnstone Biologics Appoints William Waddill to its Board of DirectorsGlobeNewswire
- Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
TSBX
Earnings
- 3/21/24 - Beat
TSBX
Sec Filings
- 5/13/24 - Form S-8
- 5/13/24 - Form 10-Q
- 5/13/24 - Form 8-K
- TSBX's page on the SEC website